MedPath

Quantification of ocular lens opacities by anterior segment tomography (Pentacam®) after radiation treatment due to endocrine orbitopathy.

Conditions
H28.1
H06.2
Cataract in other endocrine, nutritional and metabolic diseases
Dysthyroid exophthalmos
Registration Number
DRKS00028116
Lead Sponsor
Carl von Ossietzky Universität Oldenburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients after orbital irradiation at the Pius Hospital in Oldenburg due to endocrine orbitopathy from all age groups.
The control group consists of age-matched patients who come for ophthalmologic treatment to the University Outpatient Clinic for Ophthalmology at the Pius Hospital and agree to participate voluntarily in the study.

Exclusion Criteria

Implantation of an artificial lens in the past, diabetes mellitus, severe ocular trauma in the past, uveitis in the past and patients after pars plana vitrectomy

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The lens of the eye of patients after irradiation, and the eye lenses of a control group will be examined with the Pentacam.<br><br>At the end it will be determined how the lens changes can be quantified with the Pentacam.
Secondary Outcome Measures
NameTimeMethod
Measurements are taken using Pentacam and subjectively using a scale (LOCS III). In addition, the participants receive a questionnaire.
© Copyright 2025. All Rights Reserved by MedPath